Jasper Therapeutics has reported updated clinical data showing disease control in patients treated...
NEWS
Beacon Therapeutics Series C financing raises over $75 million
Beacon Therapeutics has secured more than $75 million in Series C financing to advance the...
Waterborne disease poses a growing global threat as water...
Waterborne disease is emerging as a significant and growing public health threat across both...
Breast cancer remains the world’s most-studied disease area in...
Phesi has published its latest annual analysis of global clinical development activity, based on...

